CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-27 | Humphries William D. President, Ortho-Dermatologics | Grant or award · Non-qualified Stock Options (right To Purchase) | +44,290 | 44,290 | ||
| 2019-02-27 | Herendeen Paul EVP and CFO | Grant or award | +62,915 | 289,781 | ||
| 2019-02-27 | Herendeen Paul EVP and CFO | Grant or award · Non-qualified Stock Options (right To Purchase) | +124,002 | 124,002 | ||
| 2019-02-27 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Grant or award | +15,221 | 53,446 | ||
| 2019-02-27 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Grant or award · Non-qualified Stock Options (right To Purchase) | +44,290 | 44,290 | ||
| 2019-02-27 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Grant or award | +7,610 | 69,031 | ||
| 2019-02-27 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Grant or award · Non-qualified Stock Options (right To Purchase) | +22,149 | 22,149 | ||
| 2019-02-27 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Grant or award | +21,310 | 173,950 | ||
| 2019-02-27 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Grant or award · Non-qualified Stock Options (right To Purchase) | +62,004 | 62,004 | ||
| 2019-02-27 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Grant or award | +21,310 | 69,320 | ||
| 2019-02-27 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Grant or award · Non-qualified Stock Options (right To Purchase) | +62,004 | 62,004 | ||
| 2019-01-08 | McKenna Mark C. President, Salix | Shares withheld for taxes | −1,190 | $21.25 | $25K | 19,941 |
| 2019-01-08 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Shares withheld for taxes | −2,169 | $21.25 | $46K | 38,225 |
| 2019-01-08 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −1,696 | $21.25 | $36K | 61,421 |
| 2019-01-08 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Shares withheld for taxes | −1,722 | $21.25 | $37K | 152,640 |
| 2019-01-08 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −3,446 | $21.25 | $73K | 48,010 |
| 2019-01-03 | Humphries William D. President, Ortho-Dermatologics | Shares withheld for taxes | −13,311 | $18.47 | $246K | 101,797 |
| 2018-12-31 | WECHSLER AMY B Director | Grant or award | +1,716 | $18.47 | $32K | 73,165 |
| 2018-12-31 | ROBERTSON RUSSEL C Director | Grant or award | +2,210 | $18.47 | $41K | 77,377 |
| 2018-12-31 | Paulson John Director | Grant or award | +1,488 | $18.47 | $27K | 40,699 |
Page 33 of 37 · 734 trades